RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 CRT Demonstrates Benefit in Subset of CHF Patients: The RethinQ Trial
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 7
SP 17
OP 17
DO 10.1177/155989770700700710
UL http://mdc.sagepub.com/content/7/7/17.abstract
AB This article presents the results of the Resynchronization Therapy in Normal QRS [RethinQ] study. This study was conducted in patients with New York Heart Association Class III congestive heart failure, left ventricular ejection fraction = 35%, narrow QRS (<130 ms), and evidence of mechanical dyssynchrony via echocardiography, who were candidates for an implantable cardioverter defibrillator.